BI Asset Management Fondsmaeglerselskab A S Sells 9,449 Shares of Corteva, Inc. $CTVA

BI Asset Management Fondsmaeglerselskab A S decreased its stake in Corteva, Inc. (NYSE:CTVA) by 25.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 27,027 shares of the company’s stock after selling 9,449 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Corteva were worth $2,262,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Harris Associates L P lifted its position in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares during the last quarter. Norges Bank bought a new position in Corteva during the fourth quarter valued at $504,001,000. Northwestern Mutual Wealth Management Co. increased its position in Corteva by 6,527.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after acquiring an additional 3,100,709 shares during the last quarter. Perpetual Ltd raised its stake in shares of Corteva by 78,688.5% in the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after acquiring an additional 2,612,459 shares during the period. Finally, Amundi raised its stake in shares of Corteva by 125.3% in the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after acquiring an additional 1,899,248 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CTVA shares. CICC Research lifted their price target on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. BNP Paribas Exane increased their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Wells Fargo & Company raised their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Jefferies Financial Group boosted their target price on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Finally, UBS Group cut their target price on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 9th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.81.

Corteva Trading Up 0.6%

Shares of CTVA opened at $79.36 on Wednesday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The company has a 50-day moving average of $79.45 and a 200 day moving average of $75.95. The firm has a market capitalization of $53.08 billion, a price-to-earnings ratio of 46.68, a PEG ratio of 2.41 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is presently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.